In CRC, CYP2W1 and CYP2S1 were highly expressed, while CYP1B1 and CYP2W1 were prominent in HNSCC, highlighting their potential as biomarkers and therapeutic targets. The gene discussed is CYP2S1; the disease is colorectal carcinoma.